William Rieflin – Biography
Last update: March 4, 2026Executive profile
William was Director at Rapt Therapeutics, and Director at Kallyope.
William Rieflin is currentlyChairman of the Board at Lycia Therapeutics - View - Lycia Therapeutics org chart
Chairman of the Board at NGM Biopharmaceuticals - View - NGM Biopharmaceuticals org chart
Director at Kallyope - View - Kallyope org chart
Director at Lyell Immunopharma - View - Lyell Immunopharma org chart
Create your alert
to follow the career of William Rieflin.
Education
William Rieflin has a Master of Business Administration from University of Chicago - Booth School of Business and a Juris Doctor from Stanford Law School.
They have also studied at University of Chicago - Booth School of Business :
Find more alumni from University of Chicago - Booth School of Business
More about William Rieflin
Selected links
Do you need to know more about William Rieflin? More results.
Participate
Social media
- William Rieflin on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of William Rieflin
The colleagues of William Rieflin
Company Colleagues
- At Lycia Therapeutics, William Rieflin has 17 colleagues including Aetna Wun Trombley (CEO), Clare Ozawa (Director)…
- At NGM Biopharmaceuticals, William Rieflin has 39 colleagues including Diana Peng Bockus (CEO), Shelly Guyer (Director)…
- At Kallyope, William Rieflin has 23 colleagues including Jay Galeota (CEO), Franz Humer (Chairman of the Board)…
- At Lyell Immunopharma, William Rieflin has 26 colleagues including Lynn Seely (CEO & Director), Mark Bachleda (Director)…
Industry Colleagues
- In the Biotechnology industry, William Rieflin has 35,757 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of William Rieflin.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for William Rieflin.
